🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy, as demonstrated by pr...
Status
Active Not Recruiting
Location
City of Hope 2
Start Date
2020-10-13
Trial ID
NCT04538664
Treatments Being Tested
The trial will be performed to evaluate if BIBF 1120 in combination with st...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00806819
The purpose of this study is to test the safety and efficacy of the study d...
Status
Terminated
Location
John Theurer Cancer Center
Start Date
2022-05-02
Trial ID
NCT04700176
Treatments Being Tested
Optimal management of patients with advanced NSCLC and with PS 2 remains co...
Status
Completed
Location
The Mount Sinai Comprehensive Cancer Center
Start Date
2008-04
Trial ID
NCT01836575
Treatments Being Tested
The purpose of this study is to determine whether Eribulin Mesylate Adminis...
Status
Completed
Location
Multiple Locations
Start Date
2010-06-10
Trial ID
NCT01126736
Treatments Being Tested
The primary objectives of the study are to identify a setrusumab dosing str...
Status
Active Not Recruiting
Location
Arkansas Children's Hospital
Start Date
2022-02-21
Trial ID
NCT05125809
Treatments Being Tested
This study aims first to assess the efficacy, safety, and effectiveness of ...
Status
Unknown
Location
SZUMC
Start Date
2020-03-28
Trial ID
NCT05925140
The clinical trial is a phase 1, single-arm trial that will evaluate the sa...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2021-01-13
Trial ID
NCT04150042
Treatments Being Tested
Substudy 02C is part of a larger research study that is testing experimenta...
Status
Completed
Location
The Angeles Clinic and Research Institute ( Site 3009)
Start Date
2020-06-26
Trial ID
NCT04303169
Treatments Being Tested
Scientific background. Dysregulated systemic inflammation is a key pathogen...
Status
Unknown
Location
UCSC, Policlinico Universitario A. Gemelli, ICU
Start Date
2008-02
Trial ID
NCT00562835
Treatments Being Tested